Use Of Recombinant B-Type Natriuretic Peptide In A Patient With Severe Sepsis: Renoprotective?
The Internet Journal of Emergency and Intensive Care Medicine · 2007
DOI: 10.5580/1391 ↗At a glance
Journal article in The Internet Journal of Emergency and Intensive Care Medicine, 2007.
Topics: Sepsis
Abstract (original language)
Severe sepsis complicated by acute renal failure has a high mortality. Despite severe clinical implications, a consensus on treatment and/or prevention of ARF in this setting has yet to emerge. As a potent natriuretic, renal vasodilator, and inhibitor of renin secretion, natriuretic peptide is an attractive theoretical renoprotective agent. We present a compelling case in which recombinant b-type natriuretic peptide ( rBNP) was used as adjunctive therapy to prevent acute renal failure in severe sepsis, with apparent subsequent improvement in renal function.
Cite
APA
(2007). Use Of Recombinant B-Type Natriuretic Peptide In A Patient With Severe Sepsis: Renoprotective?. The Internet Journal of Emergency and Intensive Care Medicine. https://doi.org/10.5580/1391
Vancouver
Use Of Recombinant B-Type Natriuretic Peptide In A Patient With Severe Sepsis: Renoprotective?. The Internet Journal of Emergency and Intensive Care Medicine. 2007. doi:10.5580/1391
BibTeX
@article{euvimed2007,
title = {Use Of Recombinant B-Type Natriuretic Peptide In A Patient With Severe Sepsis: Renoprotective?},
journal = {The Internet Journal of Emergency and Intensive Care Medicine},
year = {2007},
doi = {10.5580/1391}
}
EUVIMED